Stockreport

Cryoport: Picks And Shovels For The Gene Therapy Boom [Seeking Alpha]

CryoPort, Inc.  (CYRX) 
NASDAQ:AMEX Investor Relations: ir.cryoport.com
PDF CYRX supports 745 clinical trials and 19 commercial therapies, with commercial segment revenue up 36% YoY, reflecting accelerating industry adoption. Despite strong g [Read more]